CHF422.50
0.60% today
SIX Swiss Exchange, Jun 30, 05:31 pm CET
ISIN
CH0019396990
Symbol
YPSN
Sector

Ypsomed Target price 2025 - Analyst rating & recommendation

Ypsomed Classifications & Recommendation:

Buy
92%
Hold
8%

Ypsomed Price Target

Target Price CHF475.32
Price CHF422.50
Potential
Number of Estimates 9
9 Analysts have issued a price target Ypsomed 2026 . The average Ypsomed target price is CHF475.32. This is higher than the current stock price. The highest price target is
CHF519.75 23.02%
register free of charge
, the lowest is
CHF353.50 16.33%
register free of charge
.
A rating was issued by 12 analysts: 11 Analysts recommend Ypsomed to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Ypsomed stock has an average upside potential 2026 of . Most analysts recommend the Ypsomed stock at Purchase.

Sales and Margin forecast 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Mar '25 2026
Estimates
Revenue Million CHF 748.87 804.21
36.54% 7.39%
EBITDA Margin 25.74% 36.98%
12.34% 43.64%
Net Margin 11.68% 21.13%
18.23% 80.84%

8 Analysts have issued a sales forecast Ypsomed 2026 . The average Ypsomed sales estimate is

CHF804m
Unlock
. This is
7.39% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
CHF924m 23.34%
Unlock
, the lowest is
CHF647m 13.58%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 CHF749m 36.54%
2026
CHF804m 7.39%
Unlock
2027
CHF945m 17.49%
Unlock

8 Analysts have issued an Ypsomed EBITDA forecast 2026. The average Ypsomed EBITDA estimate is

CHF297m
Unlock
. This is
54.25% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
CHF354m 83.54%
Unlock
, the lowest is
CHF238m 23.52%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 CHF193m 19.69%
2026
CHF297m 54.25%
Unlock
2027
CHF361m 21.38%
Unlock

EBITDA Margin

2025 25.74% 12.34%
2026
36.98% 43.64%
Unlock
2027
38.20% 3.30%
Unlock

8 Ypsomed Analysts have issued a net profit forecast 2026. The average Ypsomed net profit estimate is

CHF170m
Unlock
. This is
94.17% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
CHF198m 125.89%
Unlock
, the lowest is
CHF139m 58.69%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 CHF87.5m 11.65%
2026
CHF170m 94.17%
Unlock
2027
CHF215m 26.68%
Unlock

Net Margin

2025 11.68% 18.23%
2026
21.13% 80.84%
Unlock
2027
22.78% 7.81%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Mar '25 2026
Estimates
Earnings Per Share CHF 6.41 12.45
11.67% 94.23%
P/E 33.74
EV/Sales 7.48

8 Analysts have issued a Ypsomed forecast for earnings per share. The average Ypsomed EPS is

CHF12.45
Unlock
. This is
94.23% higher
Unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
CHF14.48 125.90%
Unlock
, the lowest is
CHF10.17 58.66%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 CHF6.41 11.67%
2026
CHF12.45 94.23%
Unlock
2027
CHF15.77 26.67%
Unlock

P/E ratio

Current 65.52 2.18%
2026
33.74 48.51%
Unlock
2027
26.64 21.04%
Unlock

Based on analysts' sales estimates for 2026, the Ypsomed stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 8.03 18.89%
2026
7.48 6.86%
Unlock
2027
6.37 14.88%
Unlock

P/S ratio

Current 7.59 20.67%
2026
7.07 6.88%
Unlock
2027
6.02 14.88%
Unlock

Current Ypsomed Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
RESEARCH PARTNERS AG
Locked
Locked
Locked Dec 22 2024
BNP PARIBAS EXANE
Locked
Locked
Locked Nov 24 2024
ODDO BHF
Locked
Locked
Locked Nov 12 2024
Analyst Rating Date
Locked
RESEARCH PARTNERS AG:
Locked
Locked
Dec 22 2024
Locked
BNP PARIBAS EXANE:
Locked
Locked
Nov 24 2024
Locked
ODDO BHF:
Locked
Locked
Nov 12 2024

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today